BioMin Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 10


  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $362K

  • Investors
  • 4

BioMin General Information


Producer of mineral-releasing glass additives intended for oral and dental care products. The company's products include toothpaste based on special patented glasses that dissolve in saliva releasing calcium, phosphate, and fluoride, thereby enabling consumers to reduce sensitivity, rebuild enamel, and have resistance to acid attacks caused by fruit juices and fizzy drinks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Corporate Office
  • Room E204, Queens Building
  • Queen Mary University of London, London
  • Mile End E1 4NS
  • England, United Kingdom
+44 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 01-Sep-2018 $362K 00000 00.000 Completed Generating Revenue
5. Early Stage VC 11-Apr-2018 000.00 00000 Completed Generating Revenue
4. Seed Round 13-Dec-2016 00000 00000 00.000 Completed Generating Revenue
3. Seed Round 09-Dec-2014 00000 00000 00000 Completed Startup
2. Grant 01-Jan-2013 $32.8K Completed Startup
1. Spin-Off 01-Jan-2013 Completed Startup
To view BioMin’s complete valuation and funding history, request access »

BioMin Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 00 00.000000 00000.00 00000.00 00 00000.00 0.000
B Ordinary 000 00.000000 00000.00 00000.00 00 00000.00 00.000
A Ordinary 410 $0.012857 $257.14 $257.14 1x $257.14 16.41%
To view BioMin’s complete cap table history, request access »

BioMin Executive Team (5)

Name Title Board Seat Contact Info
Alec Hilton Co-Chief Executive Officer, Board Member & Managing Director
Richard Whatley Chief Executive Officer
Robert Hill Co-Founder, Chief Scientific Officer & Board Member
David Gillam Co-Founder, Board Member & Clinical Consultant
Julian Beare Chairman
To view BioMin’s complete executive team members history, request access »

BioMin Board Members (8)

Name Representing Role Since
Adam Daykin Ph.D Self Board Member 000 0000
Belinda Dolbear BioMin Board Member 000 0000
David Gillam BioMin Co-Founder, Board Member & Clinical Consultant 000 0000
Julian Beare Self Chairman 000 0000
Mike Jones BioMin Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

BioMin Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioMin Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Colin Suzman Angel (individual) Minority 000 0000 000000 0
Ironbridge Capital Partners Growth/Expansion Minority 000 0000 000000 0
Guangdong Kanwan Cosmetics Corporation Minority 000 0000 000000 0
The Armourers and Brasiers Not-For-Profit Venture Capital 000 0000 000000 0
To view BioMin’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »